𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The brain tumor microenvironment

✍ Scribed by Nikki A. Charles; Eric C. Holland; Richard Gilbertson; Rainer Glass; Helmut Kettenmann


Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
225 KB
Volume
59
Category
Article
ISSN
0894-1491

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

High‐grade brain tumors are heterogeneous with respect to the composition of bona fide tumors cells and with respect to a range of intermingling parenchymal cells. Glioblastomas harbor multiple cell types, some with increased tumorigenicity and stem cell‐like capacity. The stem‐like cells may be the cells of origin for tumor relapse. However, the tumor‐associated parenchymal cells—such as vascular cells, microglia, peripheral immune cells, and neural precursor cells—also play a vital role in controlling the course of pathology. In this review, we describe the multiple interactions of bulk glioma cells and glioma stem cells with parenchymal cell populations and highlight the pathological impact and signaling pathways known for these types of cell–cell communication. The tumor‐vasculature not only nourishes glioblastomas, but also provides a specialized niche for these stem‐like cells. In addition, microglial cells, which can contribute up to 30% of a brain tumor mass, play a role in glioblastoma cell invasion. Moreover, non‐neoplastic astrocytes can be converted into a reactive phenotype by the glioma microenvironment and can then secrete a number of factors which influences tumor biology. The young brain may have the capacity to inhibit gliomagenesis by the endogenous neural stem and progenitor cells, which secrete tumor suppressive factors. The factors, pathways, and interactions described in this review provide a new prospective on the cell biology of primary brain tumors, which may ultimately generate new treatment modalities. However, our picture of the multiple interactions between parenchymal and tumor cells is still incomplete. © 2011 Wiley‐Liss, Inc.


📜 SIMILAR VOLUMES


The brain tumor microenvironment
✍ Nikki A. Charles; Eric C. Holland; Richard Gilbertson; Rainer Glass; Helmut Kett 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 217 KB 👁 1 views

## Abstract High‐grade brain tumors are heterogeneous with respect to the composition of bona fide tumor cells and with respect to a range of intermingling parenchymal cells. Glioblastomas harbor multiple cell types, some with increased tumorigenicity and stem cell‐like capacity. The stem‐like cell

Tumor microenvironment
✍ Suresh Mohla 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 53 KB

It is my privilege to be the Guest Editor of this special edition of the Journal of Cellular Biochemistry Prospects Series focused on the ''Tumor Microenvironment.'' It is now well recognized that complex intrinsic and extrinsic influences transform a normal epithelial cell into a malignant one. En

The evolving concept of tumor microenvir
✍ Ezio Laconi 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 144 KB 👁 2 views

## Abstract The role of the microenvironment in cancer development is being increasingly appreciated. This paper will review data that highlight an emerging distinction between two different entities: the microenvironment that altered/preneoplastic/neoplastic cells find in the tissue where they res

Tumor microenvironment: The role of the
✍ Hanchen Li; Xueli Fan; JeanMarie Houghton 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 221 KB 👁 2 views

## Abstract The tumor microenvironment, composed of non‐cancer cells and their stroma, has become recognized as a major factor influencing the growth of cancer. The microenvironment has been implicated in the regulation of cell growth, determining metastatic potential and possibly determining locat

The role of the EGFR signaling in tumor
✍ Antonella De Luca; Adele Carotenuto; Annamaria Rachiglio; Marianna Gallo; Monica 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 173 KB 👁 1 views

## Abstract The epidermal growth factor receptor (EGFR) family comprehends four different tyrosine kinases (EGFR, ErbB‐2, ErbB‐3, and ErbB‐4) that are activated following binding to epidermal growth factor (EGF)‐like growth factors. It has been long established that the EGFR system is involved in t

Brain tumor epidemiology: Consensus from
✍ Melissa L. Bondy; Michael E. Scheurer; Beatrice Malmer; Jill S. Barnholtz-Sloan; 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 184 KB

Epidemiologists in the Brain Tumor Epidemiology Consortium (BTEC) have prioritized areas for further research. Although many risk factors have been examined over the past several decades, there are few consistent findings, possibly because of small sample sizes in individual studies and differences